Sana Biotechnology Inc vs Vanguard Growth Index Fund ETF — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Vanguard Growth Index Fund ETF trades at $86.16. The key difference: Vanguard Growth Index Fund ETF is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| SANA | VUG | |
|---|---|---|
Market Cap | $873.84M | — |
Sector | Health | Sector/Thematic |
52-Week High | $5.92 | $90.29 |
52-Week Low | $2.68 | $70.00 |
Enterprise Value | $848.03M | — |
Trailing returns across standard periods
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →VUG is an index-based ETF that tracks the CRSP US Large Cap Growth Index, providing concentrated exposure to the largest and fastest-growing companies in the United States. It focuses on stocks with high growth potential across tech, communication, and consumer sectors, serving as a low-cost, high-conviction core holding for long-term capital appreciation.
Read more on VUG →